Hypertensive diseases of pregnancy remains severe disease burden in developing countries and is associated with increased morbidity and mortality for both mother and the baby. This study highlights the level of morbidity and mortality associated with hypertensive pregnant mothers admitted to intensive care unit. Methods: - This retrospective study was conducted in Mogadishu Somali Turkish Training and Research Hospital from February 2019 to July 2022. The study focused on the different complications, managements and final outcomes of hypertensive pregnant mothers admitted to the Intensive care unit. Results: The mean age of studied patients was 25 ± 8years. Considering the comorbidities, 38 out of 71 patients had comorbid conditions, including a previous history of gestational hypertension 26(36.6%), a history of previous pre-eclampsia 8 (11.2%) and history of diabetics 4(5.6%). The most common reason for being taken to the intensive care unit (ICU) was having a seizure (n = 33, 46.5%), followed by having very high blood pressure (n = 20, 28.2%), and being confused (n = 18, 25.3%). Regarding the clinical characteristics of these patients, those in their 3rd trimester were the most common among them. The majority of patients, on the other hand, were primigravida (n = 53, 74.6%), and nulliparous (n = 50, 70%). Infection was the most common maternal complication during ICU admission (66.7%), followed by cardiac-related arrhythmia (66.7%), bleeding (48%), acute renal failure (18.4%), HEELP syndrome (16.4%), severe anemia (9.6%), and stroke (8.7%). Despite the fact that less than 10% of patients had severe anemia necessitating transfusion during admission, 51 (71.8%) received a transfusion for other reasons, such as severe bleeding or dialysis. 10 (14.1%) needed hemodialysis due to acute renal failure. On the other hand, 65 (91.5%) needed mechanical ventilation. For the delivery, 70 (99%) had a cesarean section, while 1 (1%) had a vaginal delivery. Out of those who had a cesarean section, 75.7% had it under general anesthesia, while the remainder (24.3%) had it under spinal anesthesia. Unfortunately, 11.1% of these patients died, and 88.9% were discharged. There were associations between mortality and some complications, especially acute renal failure (p-value less than 0.02) and infection (p-value less than 0.003). Conclusion: A hypertensive women hospitalized to an intensive care unit (ICU) have high morbidity and mortality rates. For a subsequent sizable multi-central investigation, these data serve as the foundational research.
Intensive care for a hypertensive mother with pre-eclampsia or eclampsia is crucial for both maternal and neonatal outcomes. This study highlights the level of morbidity and mortality of women with preeclampsia and eclampsia admitted in the intensive care unit. Methods: This retrospective study was conducted in Mogadishu, Somalia, Turkish Training and Research Hospital from February 2019 to July 2022. The study focused on the different complications, managements, and final outcomes of preeclampsia and eclampsia mothers admitted to the intensive care unit. The data was retrieved from the electronic records of patients admitted to the intensive care unit. Results: During our study period, a total of 237 patients were identified to have preeclampsia/eclampsia, of which 71 patients required intensive care admission. The mean age of the studied patients was 25 ± 6years. The most common reason for being taken to the intensive care unit (ICU) was having a seizure (n = 33, 46.5%), followed by having very high blood pressure (n = 20, 28.2%), and being confused (n = 18, 25.3%). Peripartum infection was the most common maternal complication during ICU admission (66.7%), followed by cardiac-related arrhythmia (66.7%), postpartum bleeding (48%), acute kidney injury (18.4%), HELLP syndrome (16.4%), severe anemia (9.6%), and stroke (8.7%). Among patients, 65 (91.5%) needed mechanical ventilation. About 11.1% of these patients died during hospitalization. There were associations between mortality and some complications, particularly acute kidney injury (p-value less than 0.02) and peripartum infection (p-value less than 0.003). Conclusion: Hypertensive disease of pregnancy (preeclampsia/eclampsia) requiring intensive care unit admission has a very high morbidity and mortality rate
A pseudoaneurysm of the left ventricle (LV) is a partial cardiac rupture surrounded by a pericardium that retains a connection with the LV lumen. Case Presentation:We present here a 30-year-old patient who came to our clinic for a routine check-up with no symptoms or complaints. After performing echocardiography, the patient's echocardiography demonstrated a left ventricular pseudo-aneurysm which had collected a massive amount of thrombus. Three years earlier, the patient had a left atrial myxoma excision with mechanical mitral valve replacement following a presentation with shortness of breath. Clinical discussion: Left ventricular pseudo-aneurysm is a hazardous complication of mostly myocardial infraction and certain cardiac procedures, such as mitral valve replacement, where it may lead to thrombus formation. Due to this condition's serious risk of lethal rupture and embolization from thrombus formation, as in our case, immediate surgical intervention is essential for its treatment. Conclusion: Left ventricular pseudo-aneurysm is an abnormal finding post-cardiac surgery, and it should be considered during patient evaluation after the surgery immediately and later in life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.